P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
a study on Breast Cancer Ovarian Cancer Lung Cancer Non-Small Cell Lung Cancer Colorectal Cancer Pancreatic Cancer Kidney Cancer Renal Cell Carcinoma Nasopharyngeal Cancer Head and Neck Squamous Cell Carcinoma Squamous Cell Carcinoma Stomach Cancer Solid Tumor
Breast Cancer Ovarian Cancer Non Small Cell Lung Cancer Colorectal Cancer Pancreatic Cancer Renal Cell Carcinoma Nasopharyngeal Cancer Head and Neck Squamous Cell Carcinoma Gastric Cancer Carcinoma Carcinoma, Renal Cell Squamous Cell Carcinoma of Head and Neck Nasopharyngeal Neoplasms Nasopharyngeal Carcinoma P-MUC1C-ALLO1 CAR-T cells Rimiducid
Lead Scientist at UCSF
- David Oh
I am a physician-scientist experienced in clinical and translational laboratory efforts to understand and improve upon cancer immunotherapies.
- accepting new patients
- Start Date
- Completion Date
- Poseida Therapeutics, Inc.
- Phase 1 research study
- Study Type
- Expecting 100 study participants
- Last Updated